Status | Study |
Completed |
Study Name: Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Condition: Leukemia Date: 2006-09-06 Interventions: Drug: asparaginase Given intra |
Completed |
Study Name: Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes Condition: Childhood Acute Basophilic Leukemia Childhood Acute Eosinophilic Leuke Date: 2006-08-24 Interventions: Drug: asparaginase Given IM |
Completed |
Study Name: Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Basophilic Leukemia Date: 2006-07-26 Interventions: Drug: vorinostat Given orally |
Completed |
Study Name: Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia Condition: Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia Date: 2006-07-13 Interventions: Drug: lenalidomide Given orally Other Names: |
Completed |
Study Name: Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia Condition: Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia Date: 2005-09-20 Interventions: Drug: Sorafenib Tosylate Given orally Other Names: |
Completed |
Study Name: Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia Condition: Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia Date: 2005-08-16 Interventions: Drug: sorafenib tosylate Given |
Terminated |
Study Name: 17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer Condition: Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia Date: 2005-02-07 Interventions: Drug: tanespimycin Given IV |
Terminated |
Study Name: Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia Condition: Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia Date: 2005-01-07 Interventions: Drug: alvocidib Given IV Other Names: |
Completed |
Study Name: Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Basophilic Leukemia Date: 2004-12-07 Interventions: Drug: tanespimycin Given IV |
Terminated |
Study Name: Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Condition: Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia Date: 2004-11-09 Interventions: Drug: idarubicin Given IV |